目的 建立蒙药扎冲十三味丸中4种成分(丁香酚、木香烃内酯、去氢木香内酯、去氢二异丁香酚)的一测多评方法(QAMS),验证该方法在蒙药扎冲十三味丸质量分析中的可行性与科学性。方法 采用高效液相色谱法(HPLC),以丁香酚为内参物,建立木香烃内酯、去氢木香内酯、去氢二异丁香酚的相对校正因子,利用相对校正因子计算蒙药扎冲十三味丸中该3种成分的含量,同时采用外标法(ESM)计算各成分的含量,并比较2种方法之间的差异。结果 木香烃内酯、去氢木香内酯、去氢二异丁香酚的相对校正因子(fS/ii)分别为 0.560 7、0.924 8、0.363 8。一测多评法与外标法测得的3个批次蒙药扎冲十三味丸样品中木香烃内酯、去氢木香内酯、去氢二异丁香酚含量的相对标准偏差(RSD)值均小于5.0%,没有显著差异。结论 以丁香酚为内参物建立的相对校正因子准确、易行,一测多评法可用于蒙药扎冲十三味丸中多指标成分的质量评价。
Abstract
OBJECTIVE To establish a quantitative analysis of multi-components by single marker (QAMS) method for four components (eugenol, costunolide, dehydrocostuslactone and dehydrodiisoeugenol) in Zhachong shisanwei pills, and verify the feasibiliy and scientificity of the method in the quality analysis of Zhachong shisanwei pills. METHODS The relative correction factors of costunolide, dehydrocostanolide and dehydrodiisoeugenol were established by HPLC with eugenol as the internal reference substance. The contents of the three components in Zhachong shisanwei pills were calculated by using the relative correction factor, and the contents of each component were calculated by external standard method (ESM), and the differences between the two methods were compared. RESULTS The relative correction factors (fS/i) of costunolide, dehydrocostuslactone and dehydrodiisoeugenol were 0.560 7, 0.924 8 and 0.363 8, respectively. The relative standard deviation(RSD) values of three batches of Mongolian medicine Zhachong shisanwei pills determined by the QAMS method and external standard method were all less than 5.0%, and there was no significant difference. CONCLUSION The relative correction factor established with eugenol as the internal reference material is accurate and easy to operate. The method of QAMS can be used for the quality evaluation of multi-index components in Mongolian medicine Zhachong shisanwei pills.
关键词
蒙药扎冲十三味丸 /
一测多评法 /
相对校正因子
{{custom_keyword}} /
Key words
Monglian medicine /
Zhachong shisanwei pills /
quantitative analysis of multi-components by single marker /
relative correction factor
{{custom_keyword}} /
中图分类号：
R917
{{custom_clc.code}}
({{custom_clc.text}})
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] Pharmacopoeia Committee of the Ministry of health of the people's Republic of China. People's Republic of China Ministry of health drug standard(中华人民共和国卫生部药品标准). Beijing: Ministry of health of the people's Republic of China Pharmacopoeia Committee, 1998: 70.
[2] TU B X. Overview of clinical application and drug action of Mongolian medicine zhachong shisanwi pill. World Latest Med Inf(世界最新医学信息文摘), 2018, 18 (10):152-153.
[3] LIU H. Pharmacological and clinical research progress of Zhachong shisan. North Pharm(北方药学), 2017, 14(5):135-136.
[4] YU T J, WANG L B,WU L J. Research progress of the chemical constituents and pharmaclogical actions of syringa linn. J Anhui Agric (安徽农业科学), 2016, 44(2):168-170.
[5] LIN M X. Pharmacology and clinical study of aucklandia sinensis. Inf Tradit Chin Med(中医药信息), 2005, 22(3):18-19.
[6] ZHANG Y, ZHANG J J, KANG W Y, et al. Advances in studies on chemical constituents and pharmacological activities of nutmeg. China J Chin Mater Med (中国中药杂志), 2014, 39(13):2438-2449.
[7] HAN Z Q, BA TU D L G. Determination of liquiritin, Ammonium glycyrrhetata, costunolide and ehydrocostus lactone in Mongolia medicine Ga Ri Di-13 pill by HPLC. World Sci Technol Mod Tradit Chin Med(世界科学技术-中医药现代化民族医药), 2015, 17(3):692-697.
[8] LI W, WU X Q,YUAN W H, et al. Determination of costcostone and dehydrocostcostone in Mongolian medicine. Chin J Ethnomed Ethnopharm (中国民族民间医药), 2017, 26(7):24-25.
[9] ZHANG H W, ZHANG Z L. Research progress of one measurement and multiple evaluation method in quality control of traditional Chinese medicine. Strait Pharm J (海峡药学),2010, 22(11):88-89.
[10] WANG Z M, QIAN Z Z, ZHANG Q W, et al. Technical guide for the establishment of one test and multiple evaluation method. China J Chin Mater Med (中国中药杂志), 2011, 36(6):657-658.
[11] WANG Z M, GAO H M, FU X T, et al. Multi-components quantitation by one marker new method for quality evaluation of Chinese herbal medicine. China J Chin Mater Med (中国中药杂志), 2006, 31(23):1925-1928.
[12] TANG A F, LI S, WANG Y J, et al. Progress and application of quantitative analysis of multi-components by single marker in pharmaceutical chemistry. Cent South Pharm (中南药学), 2014, 12(2):144-147.
[13] HE B, YANG S Y. A new method for calibration and localization of components to be measured in one measurement and multiple evaluation method. J Pharm Sci(药学学报), 2012, 47 (12):1653-1659.
[14] DOU Z H, AN L P,CHEN M, et al. Simultaneous determination of six lignanoids in schisandra chinensis by quantitative analysis of multi-components by single marker. Chin Pharm J(中国药学杂志),2014,49(2):147-151.
[15] ZHANG X L, ZHOU Q F, 列3位, et al. Simultaneous determination of six oligosaccharide esters in polygalae radix by quantitative analysis of multicomponents by singlemarker. Chin Pharm J(中国药学杂志), 2015, 50(9):808-813.
[16] LIU H, BAI Y Q, 列3位, et al. Simultaneous determination of Seven Kinds of Ingredients Content in Manglian Medicine sanchen pill by quantitative analysis of multi-components by single marker. Chin Pharm J(中国药学杂志), 2018, 53(14):1152-1159.
[17] WU C H, FENG C, 列3位, et al. Determination of four essential oils Cinnamomum cassia by quantitative analysis of multi-components by single marker. Chin Pharm J(中国药学杂志), 2019, 54(5):400-406.
[18] WANG L X, XIAO H B. A new method for improving the reproducibility of chromatographic fingerprint retention time. Br Anal Res(分析化学研究简报), 2003, 31(10):1232-1236.
[19] DU Z H, QIAO J, PIAN L, et al. Combinational quality control method of rhei radix et rhizoma based on fingerprint and QAMS. Chin Pharm J(中国药学杂志),2015,50(5):442-448.
[20] Ch.P(2020)Vol Ⅰ(中国药典2020年版.一部). 2020:414-415.
[21] LIU C X, CHEN S L, XIAO X H, et al. A new concept on quality marker of Chinese matera medica: Quality control for Chinese medicinal products. Chin Tradit Herb Drugs(中草药), 2016, 47(9):1443-1457.
[22] CHEN J L, DING Y. Simultaneous determination of seven constituents in Shexiang Xinnaole tablets by HPLC wavelength switching method. Chin J Pharm Anal (药物分析杂志), 2018, 38 (3):520-526.
{{custom_fnGroup.title_cn}}
脚注
{{custom_fn.content}}
基金
国家重点研发计划项目资助 (2018YFC1708200);内蒙古自治区科技重大专项经费资助(2019ZD004);内蒙古自治区人民政府蒙医药标准化项目资助(2020-MB019)
{{custom_fund}}
PDF(1050 KB)
